News und Analysen

EQS-News: Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia

EQS-News: Vaderis Therapeutics AG / Key word(s): Miscellaneous Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and ...weiterlesen

Seite: 1 | ... | 27 | 28 | 29 | 30 | 31 | ... | 100 ►

Aktualisiert und erweitert!